| |
| |
|
| Insider
Information: |
Purcell Dennis J |
| Relationship: |
10% Owner |
| City: |
New York |
| State: |
NY |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
4 |
|
| Direct
Shares |
5,464,340 |
|
|
Indirect Shares
|
2,830,992 |
|
|
| Direct
Value |
$21,064,568 |
|
|
|
Indirect Value
|
$492,593 |
|
|
| Total
Shares |
8,295,332 |
|
|
| Total
Value |
$21,557,160 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
ADMA Biologics Inc |
ADMA |
10% Owner |
2012-02-13 |
2,516,855 |
|
0 |
Premium* |
|
|
Loxo Oncology, Inc. |
LOXO |
10% Owner |
2018-07-10 |
2,038,920 |
|
0 |
Premium* |
|
|
T2 Biosystems, Inc. |
TTOO |
10% Owner |
2015-12-09 |
0 |
2015-12-09 |
2,830,992 |
Premium* |
|
|
Syros Pharmaceuticals, Inc. |
SYRS |
10% Owner |
2016-07-06 |
908,565 |
2016-07-06 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
16 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| LOXO |
Loxo Oncology, Inc. |
10% Owner |
– – • |
2018-07-10 |
4 |
S |
$179.43 |
$251,202,000 |
D/D |
(1,400,000) |
2,038,920 |
0 |
- |
|
| LOXO |
Loxo Oncology, Inc. |
10% Owner |
– – • |
2017-12-19 |
4 |
S |
$80.50 |
$20,125,000 |
D/D |
(250,000) |
3,438,920 |
0 |
- |
|
| LOXO |
Loxo Oncology, Inc. |
10% Owner |
– – • |
2017-11-22 |
4 |
S |
$75.00 |
$37,500,000 |
D/D |
(500,000) |
3,688,920 |
0 |
- |
|
| LOXO |
Loxo Oncology, Inc. |
10% Owner |
– – • |
2017-01-10 |
4 |
B |
$31.00 |
$4,960,000 |
D/D |
160,000 |
4,188,920 |
2.45 |
- |
|
| SYRS |
Syros Pharmaceuticals, In... |
10% Owner |
– – • |
2016-07-06 |
4 |
B |
$12.50 |
$5,000,000 |
D/D |
400,000 |
908,565 |
2.45 |
- |
|
| SYRS |
Syros Pharmaceuticals, In... |
10% Owner |
– – • |
2016-07-06 |
4 |
A |
$0.00 |
$0 |
D/D |
508,565 |
508,565 |
0 |
- |
|
| LOXO |
Loxo Oncology, Inc. |
10% Owner |
– – • |
2016-05-17 |
4 |
B |
$21.50 |
$4,999,997 |
D/D |
232,558 |
4,028,920 |
2.45 |
- |
|
| LOXO |
Loxo Oncology, Inc. |
10% Owner |
– – • |
2015-12-11 |
4 |
B |
$27.50 |
$5,500 |
D/D |
200 |
3,796,362 |
2.37 |
- |
|
| TTOO |
T2 Biosystems, Inc. |
10% Owner |
– – • |
2015-12-09 |
4 |
B |
$9.75 |
$2,999,997 |
I/I |
307,692 |
2,830,992 |
1.5 |
- |
|
| LOXO |
Loxo Oncology, Inc. |
10% Owner |
– – • |
2015-11-17 |
4 |
B |
$26.50 |
$7,022,500 |
D/D |
265,000 |
3,796,182 |
2.45 |
- |
|
| LOXO |
Loxo Oncology, Inc. |
10% Owner |
– – • |
2015-11-13 |
4 |
B |
$27.47 |
$53,704 |
D/D |
1,955 |
3,531,182 |
2.45 |
- |
|
| LOXO |
Loxo Oncology, Inc. |
10% Owner |
– – • |
2015-11-12 |
4 |
B |
$27.65 |
$2,121,319 |
D/D |
76,714 |
3,529,207 |
2.45 |
- |
|
| LOXO |
Loxo Oncology, Inc. |
10% Owner |
– – • |
2014-08-06 |
4 |
B |
$13.00 |
$5,370,001 |
D/D |
413,077 |
3,452,493 |
2.45 |
- |
|
| LOXO |
Loxo Oncology, Inc. |
10% Owner |
– – • |
2014-08-06 |
4 |
A |
$0.00 |
$0 |
D/D |
2,850,709 |
3,039,416 |
0 |
- |
|
| LOXO |
Loxo Oncology, Inc. |
10% Owner |
– – • |
2014-07-31 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
188,707 |
|
- |
|
| ADMA |
ADMA Biologics Inc |
10% Owner |
– – • |
2012-02-13 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
2,516,855 |
|
- |
|
16 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
